Back to Journals » Vascular Health and Risk Management
Vascular Health and Risk Management
ISSN: 1178-2048
ISSN 1176-6344 (Print) - went to online only in 2009
Vascular Health and Risk Management is an international, peer-reviewed open access journal focusing on the maintenance of vascular health, disease prevention, risk factors, therapeutics, monitoring and risk management of vascular disease and its sequelae. The journal also seeks to address the association between lifestyle, hypertension, vascular biology, metabolic syndrome, obesity and vascular health & disease. The journal will consider studies on drugs, drug design and development, and therapeutic use.
The journal welcomes original research, clinical and epidemiological studies, reviews and evaluations, guidelines, expert opinion and commentary.
Official journal of the International Society of Vascular Health (ISVH)
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
We are currently seeking expressions of interest for an Associate Editor position on this journal.
Please send your CV and a one-page vision statement detailing your overall objectives for the journal to Karen Benskin ([email protected]).
Articles:
- View all (1519)
- Volume 20, 2024 (23)
- Volume 19, 2023 (86)
- Volume 18, 2022 (87)
- Volume 17, 2021 (80)
- Volume 16, 2020 (60)
- Volume 15, 2019 (54)
- Volume 14, 2018 (42)
- Volume 13, 2017 (54)
- Volume 12, 2016 (52)
- Volume 11, 2015 (66)
- Volume 10, 2014 (74)
- Volume 9, 2013 (73)
- Volume 8, 2012 (74)
- Volume 7, 2011 (92)
- Volume 6, 2010 (113)
- Volume 5, 2009 (112)
- Volume 4, 2008 (164)
- Volume 3, 2007 (113)
- Volume 2, 2006 (57)
- Volume 1, 2005 (43)
Latest articles:
- 5 records -
A Double Rarity: Lost intravascular Catheter Guidewire in Persistent Left Superior Vena Cava and Coronary Sinus - A Case Report
Palić B, Goluža Sesar M, Galić K, Bogdan G, Prskalo Z
Vascular Health and Risk Management 2024, 20:245-250
Published Date: 6 June 2024
Perioperative Management in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Minor Bleeding Risk Procedure: Rationale and Protocol for the PERIXa Study
Kwon S, Lee SR, Choi EK, Lee KY, Choi J, Ahn HJ, Oh S, Lip GYH
Vascular Health and Risk Management 2024, 20:231-244
Published Date: 17 May 2024
Cardiovascular Considerations and Implications for Treatment in Psoriasis: An Updated Review
Mehta H, Narang T, Dogra S, Handa S, Hatwal J, Batta A
Vascular Health and Risk Management 2024, 20:215-229
Published Date: 10 May 2024
Retrospective Cohort Angiographic Analysis of Vertebral Artery Dominance, Stenosis Patterns, and Demographic Correlations
Qtaish I, Ayasrah M, Qtaish NR
Vascular Health and Risk Management 2024, 20:207-214
Published Date: 22 April 2024
Development and Internal Validation of a Risk Prediction Model for Carotid Atherosclerosis in the Hyperuricemia Population
Tusongtuoheti X, Huang G, Mao Y
Vascular Health and Risk Management 2024, 20:195-205
Published Date: 13 April 2024